Miller Fisher Syndrome

What is Miller Fisher syndrome?

Miller Fisher syndrome (MFS) was described by Canadian neurologist Charles Miller Fisher in 1956. It is part of the Guillain-Barre syndrome (GBS) spectrum, a group of conditions in which the immune system attacks the peripheral nerves after an infection.

In MFS, the immune system makes antibodies against a molecule called GQ1b, a ganglioside found in high concentrations in the nerves that move the eyes (cranial nerves III, IV and VI) and in sensory nerves that report joint position. Antibodies made to fight an infection cross-react with this nerve molecule, a process called molecular mimicry. That explains why the eye muscles and balance are hit hardest.

MFS accounts for roughly 1 in 20 cases of Guillain-Barre syndrome in Western countries and a larger share in East Asia. It affects men about twice as often as women, with an average age around 40.

Symptoms

Symptoms build over several days, typically peaking within 1 to 2 weeks.

The classic triad

1. Ophthalmoplegia (eye muscle weakness): double vision is usually the first symptom. Eye movements become limited in several directions. Droopy eyelids (ptosis) are common, and the pupils may react sluggishly to light.
2. Ataxia: clumsy, wide-based, unsteady walking. It comes mainly from loss of position sense rather than muscle weakness.
3. Areflexia: tendon reflexes at the knees and ankles are reduced or absent.

Other symptoms

• Facial weakness on one or both sides
• Difficulty swallowing or slurred speech
• Tingling or numbness in the hands and feet
• Blurred vision and sensitivity to light
• Mild limb weakness

About 1 in 4 people overlap with classic Guillain-Barre syndrome, developing significant limb weakness and sometimes breathing difficulties. A related condition, Bickerstaff brainstem encephalitis, shares the same antibody but adds drowsiness and brisk reflexes.

Causes and triggers

About two-thirds of people report an infection in the weeks before symptoms:

• Campylobacter jejuni gastroenteritis (food poisoning from undercooked chicken), the best-known trigger
• Haemophilus influenzae and other respiratory infections
• Viral infections including flu, cytomegalovirus, Epstein-Barr virus and COVID-19

Miller Fisher syndrome is not contagious and not inherited.

How it is diagnosed

The diagnosis is clinical, based on the triad, supported by tests:

• Anti-GQ1b antibody blood test: positive in about 85 to 90% of people with MFS. It strongly supports the diagnosis.
• Lumbar puncture: spinal fluid often shows raised protein with a normal white cell count, though this may not appear in the first week.
• Nerve conduction studies: may show reduced sensory nerve signals.
• MRI of the brain: usually normal in MFS. It is done to exclude conditions that look similar, especially a brainstem stroke.
• Breathing tests (vital capacity): repeated measurements to catch respiratory weakness early.

Conditions doctors rule out

Treatment

MFS often improves on its own, so treatment is mainly supportive:

• Hospital observation in the early phase, with regular breathing and swallowing checks
• Intravenous immunoglobulin (IVIG) or plasma exchange for people who overlap with Guillain-Barre syndrome, have limb or breathing weakness, or are worsening. In pure MFS, studies suggest IVIG may speed early improvement slightly but does not change long-term recovery.
• Eye patch or prism glasses to manage double vision
• Physical and occupational therapy for balance and safe walking
• Prevention of complications: blood clot prevention while immobile, swallowing assessment, and monitoring of heart rate and blood pressure

Steroids are not recommended for Guillain-Barre syndrome or MFS.

Recovery and outlook

The outlook is excellent for most people:

• Improvement usually starts 2 to 4 weeks after symptoms peak.
• Eye movement and balance problems typically resolve within 1 to 3 months.
• Most people return to normal within about 6 months.
• Some have mild lasting effects such as residual imbalance or fatigue.
• Recurrence is uncommon, occurring in a small percentage of people.

Deaths are rare and usually linked to overlap with severe Guillain-Barre syndrome and respiratory failure.

Frequently asked questions

What are the first symptoms of Miller Fisher syndrome?

Double vision is usually the first symptom, often with drooping eyelids. Unsteady, clumsy walking follows over a few days. Many people also notice tingling in the hands and feet. These typically appear 1 to 3 weeks after a diarrheal or respiratory infection.

How is Miller Fisher syndrome different from Guillain-Barre syndrome?

Both are immune attacks on nerves after an infection. Classic Guillain-Barre syndrome mainly causes rising weakness of the legs and arms. Miller Fisher syndrome mainly affects eye movement, balance and reflexes, with less limb weakness. MFS is linked to anti-GQ1b antibodies and usually has a better outlook.

How long does it take to recover from Miller Fisher syndrome?

Most people start improving within 2 to 4 weeks of symptoms peaking and recover fully within about 6 months. Double vision and imbalance often resolve within 1 to 3 months. A minority have mild lasting imbalance or tiredness.

Is Miller Fisher syndrome serious?

It can be frightening and needs hospital monitoring at first, because some people develop swallowing or breathing weakness. However, pure Miller Fisher syndrome usually has an excellent outcome, with full recovery in most cases and a low risk of recurrence.

Can Miller Fisher syndrome come back?

Recurrence is possible but uncommon, occurring in a small percentage of people, sometimes years later and often after another infection. A recurrent episode usually behaves like the first and also tends to recover well.